Transanal irrigation: Bridging the gap in treatment for chronic constipation and/or faecal incontinence—A systematic review and management guidance

Other authors

Institut Català de la Salut

[Vollebregt PF] Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, the Netherlands. Blizard Institute, Queen Mary University London, London, UK. [Baeten CIM] Department of Surgery, Groene Hart Hospital, Gouda, the Netherlands. [Drewes AM] Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. [Marinello F] Unitat de Cirurgia de Còlon i Recte, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Martelluci J] Emergency Sugery/Pelvic Floor Center, Careggi University Hospital, Florence, Italy. Collegium Medicum, SAN University, Lodz, Poland. [Mekhael M] Department of Surgery, Aarhus University Hospital, Aarhus, Denmark

Vall d'Hebron Barcelona Hospital Campus

Publication date

2026-03-04T07:24:03Z

2026-03-04T07:24:03Z

2025-11



Abstract

Constipation; Faecal incontinence; Irrigation


Estreñimiento; Incontinencia fecal; Irrigación


Restrenyiment; Incontinència fecal; Irrigació


Aim The aims of the study were to: (1) update a systematic review on the efficacy of transanal irrigation (TAI) in patients with chronic constipation (CC) and/or faecal incontinence (FI); (2) provide guidance on the position of TAI in the treatment pathway of CC and FI; and (3) discuss knowledge gaps and areas of future research. Method A collaborative of 11 experts (gastroenterologists, colorectal surgeons, and clinical scientists) from eight European countries was established. The expert group was divided into three main groups, with each group leading a specific section (systematic review, treatment pathway, and knowledge gaps). A previously published systematic review on TAI was updated by conducting an additional search on 12 April 2025. Studies on TAI in specific subgroups (neurogenic bowel dysfunction, low anterior resection syndrome) were excluded. Results Sixteen studies involving 1567 (range 16–507) patients were included. Only one underpowered randomised trial was performed, which demonstrated that high-volume TAI may be more effective than low-volume TAI in patients with CC. Most other studies (observational) showed improvement in symptoms and/or quality of life to some extent, with a large variation in outcomes used. Treatment discontinuation was reported in 3–57% of patients. The position of TAI in the treatment pathway of CC and FI was proposed, and 13 knowledge gaps were provided. Conclusion TAI may be an effective treatment in patients with CC and/or FI. There is a need for randomised controlled trials to study its efficacy and current knowledge gaps.


Paul F. Vollebregt received financial support from Coloplast A/S to write the manuscript.

Document Type

Article


Published version

Language

English

Publisher

Wiley

Related items

Colorectal Disease;27(11)

https://doi.org/10.1111/codi.70274

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)